Yeast reveals similar molecular mechanisms underlying alpha- and beta-synuclein toxicity

Human Molecular Genetics

Volumn 25, Issue 2, 2016, Pages 275-290

  Tenreiro, Sandra ^a,b   Rosado Ramos, Rita ^a   Gerhardt, Ellen ^c   Favretto, Filippo ^d   Magalhães, Filipa ^a   Popova, Blagovesta ^e,f   Becker, Stefan ^g   Zweckstetter, Markus ^c,d,g   Braus, Gerhard H ^e,f   Outeiro, Tiago Fleming ^b,c,d,f  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b NOVA MEDICAL SCHOOL   (Portugal)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^d GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

^f Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain   (Germany)

^g MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN; GAMMA SYNUCLEIN; SNCA PROTEIN, HUMAN; SNCB PROTEIN, HUMAN;

ARTICLE; CELL INCLUSION; CELL MIGRATION; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; EMBRYO; HUMAN; HUMAN CELL; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; YEAST; YEAST CELL; GENETICS; HEK293 CELL LINE; METABOLISM; MUTATION; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; SACCHAROMYCES CEREVISIAE; TRANSGENE; TRANSPORT VESICLE;

ALPHA-SYNUCLEIN; BETA-SYNUCLEIN; HEK293 CELLS; HUMANS; MUTATION; OXIDATIVE STRESS; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; SACCHAROMYCES CEREVISIAE; TRANSGENES; TRANSPORT VESICLES;

EID: 84960800242     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv470     Document Type: Article

References (66)

1. Lavedan, C. (1998) The synuclein family. Genome Res., 8, 871-880.
2. Greten-Harrison, B., Polydoro, M., Morimoto-Tomita, M., Diao, L.,Williams, A.M., Nie, E.H., Makani, S., Tian, N., Castillo, P.E., Buchman, V.L. et al. (2010) alphabetagamma-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction. Proc. Natl. Acad. Sci. USA, 107, 19573-19578.
3. Vargas, K.J., Makani, S., Davis, T.,Westphal, C.H., Castillo, P.E. and Chandra, S.S. (2014) Synucleins regulate the kinetics of synaptic vesicle endocytosis. J. Neurosci., 34, 9364-9376.
4. George, J.M. (2002) The synucleins. Genome Biol., 3, REVIEWS3002.
5. Mbefo, M.K., Paleologou, K.E., Boucharaba, A., Oueslati, A., Schell, H., Fournier, M., Olschewski, D., Yin, G., Zweckstetter, M., Masliah, E. et al. (2010) Phosphorylation of synucleins by members of the Polo-like kinase family. J. Biol. Chem., 285, 2807-2822.
6. Lashuel, H.A., Overk, C.R., Oueslati, A. and Masliah, E. (2013) The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat. Rev. Neurosci., 14, 38-48.
7. Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M. and Goedert, M. (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. USA, 95, 6469-6473.
8. Taschenberger, G., Toloe, J., Tereshchenko, J., Akerboom, J., Wales, P., Benz, R., Becker, S., Outeiro, T.F., Looger, L.L., Bahr, M. et al. (2013) beta-synuclein aggregates and induces neurodegeneration in dopaminergic neurons. Ann. Neurol., 74, 109-118.
9. Uversky, V.N., Li, J., Souillac, P., Millett, I.S., Doniach, S., Jakes, R., Goedert, M. and Fink, A.L. (2002) Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta-and gamma-synucleins. J. Biol. Chem., 277, 11970-11978.
10. Fan, Y., Limprasert, P., Murray, I.V., Smith, A.C., Lee, V.M., Trojanowski, J.Q., Sopher, B.L. and La Spada, A.R. (2006) Beta-synuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression. Hum. Mol. Genet., 15, 3002-3011.
11. Hashimoto, M., Rockenstein, E., Mante, M., Mallory, M. and Masliah, E. (2001) beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. Neuron, 32, 213-223.
12. Hashimoto, M., Rockenstein, E., Mante, M., Crews, L., Bar-On, P., Gage, F.H., Marr, R. and Masliah, E. (2004) An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model. Gene Ther., 11, 1713-1723.
13. Yamin, G., Munishkina, L.A., Karymov, M.A., Lyubchenko, Y. L., Uversky, V.N. and Fink, A.L. (2005) Forcing nonamyloidogenic beta-synuclein to fibrillate. Biochemistry, 44, 9096-9107.
14. Ohtake, H., Limprasert, P., Fan, Y., Onodera, O., Kakita, A., Takahashi, H., Bonner, L.T., Tsuang, D.W., Murray, I.V., Lee, V.M. et al. (2004) Beta-synuclein gene alterations in dementia with Lewy bodies. Neurology, 63, 805-811.
15. Wei, J., Fujita, M., Nakai, M.,Waragai, M.,Watabe, K., Akatsu, H., Rockenstein, E., Masliah, E. and Hashimoto, M. (2007) Enhanced lysosomal pathology caused by beta-synuclein mutants linked to dementia with Lewy bodies. J. Biol. Chem., 282, 28904-28914.
16. Fujita, M., Sugama, S., Sekiyama, K., Sekigawa, A., Tsukui, T., Nakai, M.,Waragai, M., Takenouchi, T., Takamatsu, Y.,Wei, J. et al. (2010) A beta-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain. Nat. Commun., 1, 110.
17. Fujita, M., Sekigawa, A., Sekiyama, K., Takamatsu, Y. and Hashimoto, M. (2012) Possible alterations in beta-synuclein, the non-amyloidogenic homologue of alpha-synuclein, during progression of sporadic alpha-synucleinopathies. Int. J. Mol. Sci., 13, 11584-11592.
18. Clayton, D.F. and George, J.M. (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci., 21, 249-254.
19. Surgucheva, I., McMahan, B., Ahmed, F., Tomarev, S.,Wax, M. B. and Surguchov, A. (2002) Synucleins in glaucoma: implication of gamma-synuclein in glaucomatous alterations in the optic nerve. J. Neurosci. Res., 68, 97-106.
20. Galvin, J.E., Giasson, B., Hurtig, H.I., Lee, V.M. and Trojanowski, J.Q. (2000) Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology. Am. J. Pathol., 157, 361-368.
21. Galvin, J.E., Uryu, K., Lee, V.M. and Trojanowski, J.Q. (1999) Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gammasynuclein. Proc. Natl. Acad. Sci. USA, 96, 13450-13455.
22. Peters, O.M., Shelkovnikova, T.,Highley, J.R., Cooper-Knock, J., Hortobagyi, T., Troakes, C., Ninkina, N. and Buchman, V.L. (2015) Gamma-synuclein pathology in amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol., 2, 29-37.
23. Chen, L. and Feany, M.B. (2005) Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat Neurosci., 8, 657-663.
24. Smith, W.W., Margolis, R.L., Li, X., Troncoso, J.C., Lee, M.K., Dawson, V.L., Dawson, T.M., Iwatsubo, T. and Ross, C.A. (2005) Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells. J. Neurosci., 25, 5544-5552.
25. Gao, H.M., Kotzbauer, P.T., Uryu, K., Leight, S., Trojanowski, J. Q. and Lee, V.M. (2008) Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J. Neurosci., 28, 7687-7698.
26. Koob, A.O., Ubhi, K., Paulsson, J.F., Kelly, J., Rockenstein, E., Mante, M., Adame, A. and Masliah, E. (2010) Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies. Exp. Neurol., 221, 267-274.
27. Anderson, J.P.,Walker,D.E., Goldstein, J.M., de Laat, R., Banducci, K., Caccavello, R.J., Barbour, R., Huang, J., Kling, K., Lee, M. et al. (2006) Phosphorylation of Ser-129 is the dominant pathologicalmodification of alpha-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem., 281, 29739-29752.
28. Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M.S., Shen, J., Takio, K. and Iwatsubo, T. (2002) alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol., 4, 160-164.
29. Tenreiro, S., Eckermann, K. and Outeiro, T.F. (2014) Protein phosphorylation in neurodegeneration: friend or foe? Front. Mol. Neurosci., 7, 42.
30. Mahul-Mellier, A.L., Fauvet, B., Gysbers, A., Dikiy, I., Oueslati, A., Georgeon, S., Lamontanara, A.J., Bisquertt, A., Eliezer, D., Masliah, E. et al. (2014) c-Abl phosphorylates alpha-synuclein and regulates its degradation: implication for alpha-synuclein clearance and contribution to the pathogenesis of Parkinson's disease. Hum. Mol. Genet., 23, 2858-2879.
31. Paleologou, K.E., Oueslati, A., Shakked, G., Rospigliosi, C.C., Kim, H.Y., Lamberto, G.R., Fernandez, C.O., Schmid, A., Chegini, F., Gai,W.P. et al. (2010) Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions. J. Neurosci., 30, 3184-3198.
32. Nakajo, S., Tsukada, K., Omata, K., Nakamura, Y. and Nakaya, K. (1993) A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation. Eur. J. Biochem., 217, 1057-1063.
33. Tenreiro, S., Munder, M.C., Alberti, S. and Outeiro, T.F. (2013) Harnessing the power of yeast to unravel the molecular basis of neurodegeneration. J. Neurochem., 127, 438-452.
34. Mumberg, D., Muller, R. and Funk, M. (1995) Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene, 156, 119-122.
35. Outeiro, T.F. and Lindquist, S. (2003) Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science, 302, 1772-1775.
36. Tenreiro, S., Reimao-Pinto, M.M., Antas, P., Rino, J., Wawrzycka, D., Macedo, D., Rosado-Ramos, R., Amen, T., Waiss, M., Magalhaes, F. et al. (2014) Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson's disease. PLoS Genet., 10, e1004302.
37. Flower, T.R., Chesnokova, L.S., Froelich, C.A., Dixon, C. and Witt, S.N. (2005) Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease. J. Mol. Biol., 351, 1081-1100.
38. Su, L.H.J., Auluck, P.K., Outeiro, T.F., Yeger-Lotem, E., Kritzer, J. A., Tardiff, D.F., Strathearn, K.E., Liu, F., Cao, S.S., Hamamichi, S. et al. (2010) Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models. Dis. Model Mech., 3, 194-208.
39. Macedo, D., Tavares, L., McDougall, G.J., Vicente Miranda, H., Stewart, D., Ferreira, R.B., Tenreiro, S., Outeiro, T.F. and Santos, C.N. (2015) (Poly)phenols protect from alpha-synuclein toxicity by reducing oxidative stress and promoting autophagy. Hum. Mol. Genet., 24, 1717-1732.
40. Cooper, A.A., Gitler, A.D., Cashikar, A., Haynes, C.M., Hill, K.J., Bhullar, B., Liu, K., Xu, K., Strathearn, K.E., Liu, F. et al. (2006) Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science, 313, 324-328.
41. Outeiro, T.F., Putcha, P., Tetzlaff, J.E., Spoelgen, R., Koker, M., Carvalho, F., Hyman, B.T. and McLean, P.J. (2008) Formation of toxic oligomeric alpha-synuclein species in living cells. PLoS One, 3, e1867.
42. Bertoncini, C.W., Jung, Y.S., Fernandez, C.O., Hoyer, W., Griesinger, C., Jovin, T.M. and Zweckstetter, M. (2005) Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. Proc. Natl. Acad. Sci. USA, 102, 1430-1435.
43. Wu, K.P. and Baum, J. (2010) Detection of transient interchain interactions in the intrinsically disordered protein alpha-synuclein by NMR paramagnetic relaxation enhancement. J. Am. Chem. Soc., 132, 5546-5547.
44. Gitler, A.D., Chesi, A., Geddie, M.L., Strathearn, K.E., Hamamichi, S., Hill, K.J., Caldwell, K.A., Caldwell, G.A., Cooper, A.A., Rochet, J.C. et al. (2009) alpha-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat. Genet., 41, 308-315.
45. Sancenon, V., Lee, S.A., Patrick, C., Griffith, J., Paulino, A., Outeiro, T.F., Reggiori, F., Masliah, E. and Muchowski, P.J. (2012) Suppression of-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context. Hum. Mol. Genet., 21, 2432-2449.
46. Soper, J.H., Roy, S., Stieber, A., Lee, E.,Wilson, R.B., Trojanowski, J.Q., Burd, C.G. and Lee, V.M.Y. (2008) alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. Mol. Biol. Cell, 19, 1093-1103.
47. Willingham, S., Outeiro, T.F., DeVit, M.J., Lindquist, S.L. and Muchowski, P.J. (2003) Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science, 302, 1769-1772.
48. Sekigawa, A., Takamatsu, Y., Sekiyama, K. and Hashimoto, M. (2015) Role of alpha-and beta-synucleins in the axonal pathology of Parkinson's disease and related synucleinopathies. Biomolecules, 5, 1000-1011.
49. Gitler, A.D., Bevis, B.J., Shorter, J., Strathearn, K.E., Hamamichi, S., Su, L.J., Caldwell, K.A., Caldwell, G.A., Rochet, J.C., McCaffery, J.M. et al. (2008) The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc. Natl. Acad. Sci. USA, 105, 145-150.
50. Zabrocki, P., Pellens, K., Vanhelmont, T., Vandebroek, T., Griffioen, G., Wera, S., Van Leuven, F. and Winderickx, J. (2005) Characterization of alpha-synuclein aggregation and synergistic toxicity with protein tau in yeast. FEBS J., 272, 1386-1400.
51. Oien, D.B., Shinogle, H.E., Moore, D.S. and Moskovitz, J. (2009) Clearance and phosphorylation of alpha-synuclein are inhibited in methionine sulfoxide reductase a null yeast cells. J. Mol. Neurosci., 39, 323-332.
52. Pals, P., Lincoln, S., Manning, J., Heckman, M., Skipper, L., Hulihan, M., Van den Broeck, M., De Pooter, T., Cras, P., Crook, J. et al. (2004) Alpha-synuclein promoter confers susceptibility to Parkinson's disease. Ann. Neurol., 56, 591-595.
53. Tan, E.K., Chai, A., Teo, Y.Y., Zhao, Y., Tan, C., Shen, H., Chandran, V.R., Teoh, M.L., Yih, Y., Pavanni, R. et al. (2004) Alphasynuclein haplotypes implicated in risk of Parkinson's disease. Neurology, 62, 128-131.
54. Chiba-Falek, O., Kowalak, J.A., Smulson, M.E. and Nussbaum, R.L. (2005) Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACPRep1 polymorphic site upstream of the SNCA gene. Am. J. Hum. Genet., 76, 478-492.
55. Park, J.Y. and Lansbury, P.T. Jr. (2003) Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease. Biochemistry, 42, 3696-3700.
56. Alberti, S., Gitler, A.D. and Lindquist, S. (2007) A suite of Gateway cloning vectors for high-throughput genetic analysis in Saccharomyces cerevisiae. Yeast, 24, 913-919.
57. Thomas, B.J. and Rothstein, R. (1989) Elevated recombination rates in transcriptionally active DNA. Cell, 56, 619-630.
58. Wendland, J. (2003) PCR-based methods facilitate targeted gene manipulations and cloning procedures. Curr. Genet., 44, 115-123.
59. Owusu-Ansah, E., Yavari, A. and Banerjee, U. (2008) A protocol for in vivo detection of reactive oxygen species. Protoc. Exchange, doi: 10.1038/nprot.2008.1023.
60. Tetzlaff, J.E., Putcha, P., Outeiro, T.F., Ivanov, A., Berezovska, O., Hyman, B.T. and McLean, P.J. (2008) CHIP targets toxic alpha-Synuclein oligomers for degradation. J. Biol. Chem., 283, 17962-17968.
61. Hoyer, W., Antony, T., Cherny, D., Heim, G., Jovin, T.M. and Subramaniam, V. (2002) Dependence of alpha-synuclein aggregate morphology on solution conditions. J. Mol. Biol., 322, 383-393.
62. Fawzi, N.L., Fleissner, M.R., Anthis, N.J., Kalai, T., Hideg, K., Hubbell, W.L. and Clore, G.M. (2011) A rigid disulfide-linked nitroxide side chain simplifies the quantitative analysis of PRE data. J. Biomol. NMR, 51, 105-114.
63. Mori, S., Abeygunawardana, C., Johnson, M.O. and van Zijl, P. C. (1995) Improved sensitivity of HSQC spectra of exchanging protons at short interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation. J. Magn. Reson. B, 108, 94-98.
64. Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J. and Bax, A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR, 6, 277-293.
65. Vranken,W.F., Boucher,W., Stevens, T.J., Fogh, R.H., Pajon, A., Llinas, M., Ulrich, E.L., Markley, J.L., Ionides, J. and Laue, E.D. (2005) The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins, 59, 687-696.
66. Bertoncini, C.W., Rasia, R.M., Lamberto, G.R., Binolfi, A., Zweckstetter, M., Griesinger, C. and Fernandez, C.O. (2007) Structural characterization of the intrinsically unfolded protein beta-synuclein, a natural negative regulator of alpha-synuclein aggregation. J. Mol. Biol., 372, 708-722.